~25 spots leftby Aug 2025

Adaptive Autism Intervention for Toddlers with Autism

(CAIT Trial)

Age: < 18
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of California, Los Angeles
No Placebo Group
Approved in 1 Jurisdiction

Trial Summary

What is the purpose of this trial?

This trial tests a program to help toddlers with autism improve their social and communication skills. The program starts with play-based activities and is adjusted based on each child's progress. These activities have been shown to improve social communication in young children with autism. The goal is to find the best way to support these children in everyday settings.

Do I need to stop my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It focuses on behavioral interventions for toddlers with autism.

What data supports the idea that Adaptive Autism Intervention for Toddlers with Autism is an effective treatment?

The available research shows that Adaptive Autism Intervention for Toddlers with Autism, such as JASPER, is effective in improving language and play skills in young children with autism. One study found that children who received joint attention and play interventions showed greater improvements in language skills compared to those who did not receive these interventions. Another study demonstrated that teachers could successfully implement these interventions in classrooms, leading to significant improvements in joint attention and play skills. Additionally, a pilot study showed that minimally verbal children with autism who received JASPER treatment had more diverse play and better engagement in the classroom. These findings suggest that this treatment can effectively enhance important developmental skills in children with autism.12345

What safety data exists for the Adaptive Autism Intervention for Toddlers with Autism?

The studies provided do not directly address safety data for the intervention. However, they suggest that interventions like JASPER, which focus on joint attention and play, are beneficial and can be implemented in various settings (classroom, parent-mediated) without reported adverse effects. These interventions have shown improvements in joint attention, play skills, and language outcomes in young children with autism, indicating they are generally well-tolerated and effective.13456

Is JASPER a promising treatment for toddlers with autism?

Yes, JASPER is a promising treatment for toddlers with autism. It helps improve important skills like joint attention and play, which are crucial for social interaction and communication. Studies show that children who receive JASPER make significant progress in these areas, and even brief sessions can lead to noticeable improvements.14567

Research Team

Eligibility Criteria

This trial is for toddlers aged 2-3 with autism spectrum disorder (ASD) who are receiving early intervention in East Harlem and the Bronx, NY. They must have a clinical ASD diagnosis or ADOS-2 confirmation, and their caregivers must consent to learn intervention strategies if required. Children with co-morbid disorders like cerebral palsy or Down syndrome cannot participate.

Inclusion Criteria

My caregiver agrees to learn and use new care strategies if needed.
Diagnosis of ASD based on clinical report or ADOS-2 if needed
I am under 3 years old.

Exclusion Criteria

The child has other health conditions like cerebral palsy or Down syndrome.

Treatment Details

Interventions

  • jasPEER (Behavioural Intervention)
  • JASPER (Behavioural Intervention)
  • JASPER Plus+ (Behavioural Intervention)
  • Structured Teaching (Behavioural Intervention)
Trial OverviewThe study tests an adaptive autism intervention called JASPER, alone or combined with structured teaching (JASPER Plus+), tailored based on the child's initial response. It aims to improve social communication and cognitive outcomes over a year through two phases of individualized treatment involving daily sessions.
Participant Groups
2Treatment groups
Active Control
Group I: JASPER (6 weeks)Active Control2 Interventions
Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 6 weeks. If child is an early responder, he/she will continue to do JASPER daily, 5 times a week, for the remaining 18 weeks of the study. If child is a slow responder, he/she can get randomized to receive 30 minutes of JASPER Plus+ and 30 minutes of JASPER with a TA daily, 5 days a week for the remaining 18 weeks of the study. Or Child can get randomized to continue his/her daily sessions of JASPER with the TA for an hour each day, 5 days a week for the following 18 weeks of the study.
Group II: JASPER (12 weeks)Active Control2 Interventions
Child will be randomized to spend an hour daily, 5 days a week with teaching assistant (TA) doing JASPER for the following 12 weeks. If child is an early responder, he/she will do JASPER for 60 minutes with TA, 5 times a week, for the remaining 12 weeks of the study. If child is a slow responder, he/she can get randomized to receive 30 minutes of JASPER Plus+ and 30 minutes of JASPER with a TA daily, 5 days a week for the remaining 12 weeks of the study. Or Child can get randomized to continue his/her daily sessions of JASPER with the TA for an hour each day, 5 days a week for the following 12 weeks of the study.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Los Angeles

Lead Sponsor

Trials
1,594
Recruited
10,430,000+
Dr. Thomas Rando profile image

Dr. Thomas Rando

University of California, Los Angeles

Chief Medical Officer since 2023

MD from UCLA

Amir Naiberg profile image

Amir Naiberg

University of California, Los Angeles

Chief Executive Officer since 2024

JD from UCLA

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+
Dr. Jeanne Marrazzo profile image

Dr. Jeanne Marrazzo

National Institutes of Health (NIH)

Chief Medical Officer

MD from University of California, Los Angeles

Dr. Jay Bhattacharya profile image

Dr. Jay Bhattacharya

National Institutes of Health (NIH)

Chief Executive Officer

MD, PhD from Stanford University

Findings from Research

In a study involving 58 preschool children with autism, both joint attention (JA) and symbolic play (SP) interventions led to greater expressive language gains compared to a control group after 5-6 weeks of daily sessions.
Children with the lowest initial language levels showed significantly better language outcomes from the JA intervention compared to the SP and control groups, highlighting the importance of targeting JA skills in early autism treatment.
Language outcome in autism: randomized comparison of joint attention and play interventions.Kasari, C., Paparella, T., Freeman, S., et al.[2022]
Toddlers diagnosed with autism spectrum disorder (ASD) demonstrated significantly less pretend play and social engagement during interactions compared to low-risk toddlers with typically-developing siblings and high-risk toddlers without a diagnosis.
The study found that lower levels of pretend play and social engagement in high-risk toddlers were linked to more severe symptoms of ASD, suggesting that these behaviors may be early indicators of emerging autism.
Pretend Play and Social Engagement in Toddlers at High and Low Genetic Risk for Autism Spectrum Disorder.Campbell, SB., Leezenbaum, NB., Mahoney, AS., et al.[2019]
The study found that the quality of interaction between toddlers and their caregivers significantly influences the development of play behavior, highlighting the importance of caregiver engagement.
For toddlers with autism, the security of attachment to their caregivers was a stronger predictor of play behavior than the autism diagnosis itself, suggesting that nurturing relationships can enhance social development.
Play behavior and attachment in toddlers with autism.Naber, FB., Bakermans-Kranenburg, MJ., van Ijzendoorn, MH., et al.[2018]

References

Language outcome in autism: randomized comparison of joint attention and play interventions. [2022]
Pretend Play and Social Engagement in Toddlers at High and Low Genetic Risk for Autism Spectrum Disorder. [2019]
Play behavior and attachment in toddlers with autism. [2018]
A play and joint attention intervention for teachers of young children with autism: a randomized controlled pilot study. [2019]
Preschool based JASPER intervention in minimally verbal children with autism: pilot RCT. [2021]
Promoting joint attention in toddlers with autism: a parent-mediated developmental model. [2019]
Sustained Community Implementation of JASPER Intervention with Toddlers with Autism. [2020]